On March 21, 2017, a new update was released from the Food and Drug Administration regarding BIA-ALCL has the media buzzing with talk of serious illness and safety. Seemingly none of the talk, however, is giving patients much real information.
Dr. Bill Adams, Associate Clinical Professor, Department of Plastic Surgery at UT Southwestern, Board member for the American Society of Aesthetic Plastic Surgery, and ASPS/ ASAP BI-ALCL Taskforce member and Dr. Jamil Ahmad, Assistant Professor, Division of Plastic and Reconstructive Surgery at the University of Toronto, and Board member for the American Society of Aesthetic Plastic Surgery, have received a number of calls from their patients who are now worried by the news coverage and are searching for real answers. Breast Implant ALCL is not a new topic for these two surgeons, the plastic surgery community, breast implant industry or the FDA. In fact, research and studies have been going on for years now to provide scientific data, real solutions and treatments.